Business Standard

Ajanta Pharma Share Price

Know More
BSENSE

2,088.65 7.65 (0.37%)

04:01 PM,19th Apr 2024

2,085.40 6.55 (0.32%)

03:52 PM,19th Apr 2024

BSE : 532331

NSE : AJANTPHARM

Sector : Health care

ISIN Code : INE031B01049

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 19-Apr-2024 | 04:01 PM IST

Market Cap (₹ Cr)

26,296

Turnover (₹ Cr)

0.04

Volume (Shares)

1,788

Face Value

2

52-WK High

2,355.05

52-WK High Date

04-Jan-2024

52-WK Low

1,240.55

52-WK Low Date

15-May-2023

All Time High

2,355.05

All Time High Date

04-Jan-2024

All Time Low

1.88

All Time Low Date

01-Apr-2003

Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India the Rest of Asia and Africa. The Company is involved in development manufacturing and marketing of marketing of quality finished dosages in domestic and international markets. It produces a comprehensive range of specialty products targeting different therapeutic segments. It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa Generics in the developed markets of USA and Instituti...
Read More

Ajanta Pharma Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>AJANTA PHARMA LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230MH1979PLC022059</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A1+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>NSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Gaurang Shah <br/> Designation: VP Legal and Company Secretary <br/> EmailId: gaurang.shah@ajantapharma.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Arvind Agrawal <br/> Designation: CFO <br/> EmailId: arvind.agrawal@ajantapharma.com</div> </div> <div> <br/> Date: 15/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Ajanta Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

26,255

EPS - TTM (₹) [S]

60.50

P/E Ratio (X) [S]

7.82

Face Value (₹) 2
Latest Dividend (%)1,300.00
Latest Dividend Date 08-Feb-2024
Dividend Yield (%) 0.34
Book Value Share (₹) [S]266.51
P/B Ratio (₹) [S]7.82

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Nippon India Small Cap Fund (G) 405.15 18,16,137 0.89
Nippon India Small Cap Fund (B) 405.15 18,16,137 0.89
Nippon India Small Cap Fund - Direct (B) 405.15 18,16,137 0.89
Nippon India Small Cap Fund - Direct (G) 405.15 18,16,137 0.89
UTI-Flexi Cap Fund (IDCW) 361.98 16,22,626 1.48
UTI-Flexi Cap Fund (G) 361.98 16,22,626 1.48
UTI-Flexi Cap Fund - Direct (G) 361.98 16,22,626 1.48
Kotak Small Cap Fund (IDCW) 221.36 9,92,271 1.59
Kotak Small Cap Fund (G) 221.36 9,92,271 1.59
Kotak Small Cap Fund - Direct (G) 221.36 9,92,271 1.59

Load more

Research Reports

Date Broker Action Prices(₹) Report
15-Mar-2023Motilala Oswal Buy 1,216

Stock Strength

Today's Low/High

2,069.15

2,107.95

Week Low/High

2,051.60

2,207.00

Month Low/High

2,051.60

2,318.00

Year Low/High

1,246.75

2,354.00

All time Low/High

1.88

2,354.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-1.62%-1.41%-1.56-1.65%
1 Month-0.93%-1.14%1.491.51%
3 Month-5.13%-5.25%1.962.43%
6 Month17.84%17.69%11.3712.85%
1 Year60.19%60.21%22.7025.70%
3 Year80.72%79.91%52.4354.23%

Company Info

Company Information

Chairman (Non-Executive) : Mannalal B Agrawal

Vice Chairman : Madhusudan B Agrawal

Managing Director : Yogesh Agrawal

Independent Director : Chandrakanth M Khetan

Vice President & CS : Gaurang Shah

Joint Managing Director : Rajesh M Agrawal

Independent Director : K H Viswanathan

Independent Director : Prabhakar Dalal

Independent Director : Anjana Grewal

Registered Office: Ajanta House, Charkop Kandivli (W),Mumbai,Maharashtra-400067 Ph: 91-22-66061000/1204/1203

Email:info@ajantapharma.com; investorgrievance@ajantapha

URL:http://www.ajantapharma.com